Drug approvals in U.S. continue to decline (The News Journal)
U.S. regulators approved 18 new drugs in 2006, close to an eight-year low, as drug makers struggled to develop products for hard-to-treat disorders.

Endo Pharmaceuticals Provides Financial Guidance for 2007 (RedNova)
Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), a market leader in pain management, today provided financial guidance for fiscal year 2007. Commenting on the guidance, President and Chief Executive Officer Peter A.